STOCK-BASED COMPENSATION (Tables)

3 Months Ended

Jun. 30, 2026

Share-Based Payment Arrangement [Abstract]

Schedule of Stock Options

The following table summarizes the activity relating to the Company’s market-based stock options for the three-month period ended June 30, 2026:

	Options (in thousands)	Weighted- Average Exercise Price ($)	Weighted-Average Contractual Remaining Term (years)	Aggregate Intrinsic Values (in thousands)
Outstanding as of April 1, 2026	5,090	14.09	—	—
Granted	—	—	—	—
Exercised	—	—	—	—
Forfeited	—	—	—	—
Outstanding as of June 30, 2026	5,090	14.09	5.68	$	687
Exercisable as of June 30, 2026	—	—	—	$	—

The following table summarizes the activity relating to the Company’s stock options, excluding the market-based stock options, for the three-month period ended June 30, 2026:

	Options (in thousands)	Weighted- Average Exercise Price ($)	Weighted-Average Contractual Remaining Term (years)	Aggregate Intrinsic Values (in thousands)
Outstanding as of April 1, 2026	1,807	4.51	—	—
Granted	—	—	—	—
Exercised	—	—	—	—
Forfeited	(182)	4.66	—	—
Outstanding as of June 30, 2026	1,625	4.49	5.50	$	346
Exercisable as of June 30, 2026	1,575	4.50	5.42	$	346

Schedule of Restricted Stock Activity

A summary of all unvested restricted stock, RSUs and PSUs for the three-month period ended June 30, 2026 is as follows:

	Time-Based Awards		Market-Based Awards		Performance-Based Awards
	Number of Unvested Shares (in thousands)	Weighted- Average Grant Date Fair Value ($)	Number of Unvested Shares (in thousands)	Weighted- Average Grant Date Fair Value ($)	Number of Unvested Shares (in thousands)	Weighted- Average Grant Date Fair Value ($)
Unvested, March 31, 2026	1,985	4.24	834	5.35	3,993	4.05
Granted	—	—	—	—	—	—
Vested/Exercised	(1)	4.75	—	—	—	—
Forfeited or expired	—	—	—	—	—	—
Unvested, June 30, 2026	1,984	4.23	834	5.35	3,993	3.62

Schedule of Unvested SARs Activities

The following table summarizes the activity relating to the Company’s stock appreciation rights (“SARs”) for the three-month period ended June 30, 2026:

	Number of SARs (in thousands)	Weighted- Average Exercise Price ($)	Weighted-Average Contractual Remaining Term (years)	Aggregate Intrinsic Values (in thousands)
Outstanding as of April 1, 2026	2,369	2.36
Granted	—	—
Exercised	(312)	2.52
Forfeited	0	—
Outstanding as of June 30, 2026	2,057	2.34	2.26
Exercisable as of June 30, 2026	971	2.42	2.06	$	1,367

Schedule of Fair Value Valuation Assumptions

The fair value of each warrant on grant date is estimated using the Black-Scholes option-pricing model reflecting the following assumptions:

Expected volatility	70.0		%
Expected life of warrants	5.2
Risk free interest rate	4.0		%
Dividend yield	—
Fair value of warrants granted during the quarter	$	2.79